CSF2 and non-small cell lung carcinoma: GVAX is a genetically engineered irradiated autologous or allogeneic to secrete Granulocyte-macrophage colony stimulating factor (GM-CSF).64 GVAX’s first round of clinical study included patients with stage IV NSCLC, demonstrated favorable safety and tolerability profiles.